The SURPASS trials are designed to evaluate once-weekly tirzepatide doses of 5 mg, 10 mg, and 15 mg with a dose escalation algorithm: starting dose at 2.5 mg weekly for the first 4 weeks, then dose increment of 2.5 mg every 4 weeks until the maintenance dose of 5 mg, 10 mg, or 15 mg is achieved
The profound fatigue, the cognitive fog that clouds your thinking, and the post-exertional crashes are not merely "in your head"they are the tangible, debilitating results of measurable physiological dysfunction
03:53 Mon, Feb 9 20267:14 PM EST
Da Silva AP, Marinho C, Gonalves MC, Monteiro C, Laires MJ, Falco LM, Nogueira JB, Bich M
What is the mechanism of action for GLP-1 medications like Ozempic in promoting weight loss
Stopping nosebleeds, which are medically termed as epistaxis